Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D53NSY
|
|||
| Drug Name |
TEV-56286
|
|||
| Synonyms |
Emrusolmin
Click to Show/Hide
|
|||
| Indication | Multiple system atrophy [ICD-11: 8D87.0] | Phase 1 | [1] | |
| Company |
Teva Pharmaceutical
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05532358) An Open-Label, One-Sequence, Two-Part Drug-Drug Interaction Study in Healthy Volunteers to Assess the CYP1A2 and CYP3A4 Perpetrator Interaction Potential and CYP1A2 Victim Potential of TEV-56286 (anle138b). U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.